LEADER 01523nam  2200385 a 450 
001 9910700341103321
005 20110517091147.0
035   $a(CKB)5470000002409577
035   $a(OCoLC)724459636
035   $a(EXLCZ)995470000002409577
100   $a20110517d2010      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFood and Drug Administration$b[electronic resource] $eresponse to heparin contamination helped protect public health; controls that were needed for working with external entities were recently added : report to the Ranking Member, Committee on Energy and Commerce, House of Representatives
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2010]
215   $a1 online resource (iii, 57 pages) $cillustrations
300   $aTitle from PDF title screen (GAO, viewed May 11, 2011).
300   $a"October 2010."
300   $a"GAO-11-95."
320   $aIncludes bibliographical references.
517   $aFood and Drug Administration 
606   $aHeparin
606   $aDrug adulteration$xPrevention$xGovernment policy$zUnited States
615  0$aHeparin.
615  0$aDrug adulteration$xPrevention$xGovernment policy
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910700341103321
996   $aFood and Drug Administration$93425941
997   $aUNINA